Clinical Trial Update: IMPACT Non Hodgkins Lymphoma (NHL) Study

View source ↗

Summary

Amgen's IMPACT trial in non-Hodgkin's lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Amgen | Conditions: Non-Hodgkin's Lymphoma | Status: COMPLETED